δ antagonist and κ agonist activity of naltriben: Evidence for differential κ interaction with the δ1 and δ2 opioid receptor subtypes
- 1 January 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 55 (4) , PL79-PL84
- https://doi.org/10.1016/0024-3205(94)00738-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 7-Benzylidenenaltrexone (BNTX): A selective δ1 opioid receptor antagonist in the mouse spinal cordLife Sciences, 1993
- Pharmacology of the Spinal Action of Ketorolac, Morphine, ST-91, U50488H, and L-PIA on the Formalin Test and an Isobolographic Analysis of the NSAID InteractionAnesthesiology, 1993
- Agonist and antagonist activities of ligands derived from naltrexone and oxymorphoneLife Sciences, 1992
- Long term κ-opioid receptor blockade following nor-binaltorphimineEuropean Journal of Pharmacology, 1992
- Role of spacer and address components in peptidomimetic .delta.-opioid receptor antagonists related to naltrindoleJournal of Medicinal Chemistry, 1991
- Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanismJournal of Neuroscience, 1990
- Effect of κ-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant ratsEuropean Journal of Pharmacology, 1988
- U50,488H differentially antagonizes the bladder effects of μ agonists at spinal sitesEuropean Journal of Pharmacology, 1988
- Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonistsJournal of Medicinal Chemistry, 1988
- Intrathecally administered dynorphin-(1–17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant ratsEuropean Journal of Pharmacology, 1987